$JXN
Jackson Financial Inc. Stock $jxn

$jxn Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000182299323000024 Filed on May 09, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q4
Revenue	$2.221B	$9.863B	-$381.0M
YoY Change	-65.93%	129.32%	-123.29%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.042B	$1.022B	$997.0M
YoY Change	15.27%	3.02%	-5.84%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$317.0M	$1.226B
YoY Change	10466.67%	40766.67%
% of Gross Profit
Operating Expenses	-$1.113B	$1.262B	$532.0M
YoY Change	-139.14%	-33.4%	-37.89%
Operating Profit
YoY Change
Interest Expense	$58.00M	$43.00M	-$40.00M
YoY Change	141.67%	115.0%	122.22%
% of Operating Profit
Other Income/Expense, Net	-$24.00M	-$36.00M	-$106.0M
YoY Change	-138.71%	-250.0%	709.16%
Pretax Income	$2.613B	$7.734B	-$953.0M
YoY Change	-28.43%	224.14%	-227.36%
Income Tax	$388.0M	$1.505B	-$235.0M
% Of Pretax Income	14.85%	19.46%
Net Earnings	$2.194B	$6.186B	-$710.0M
YoY Change	-24.42%	205.48%	-221.31%
Net Earnings / Revenue	98.78%	62.72%
Basic Earnings Per Share	$25.41	$72.34	-$8.48
Diluted Earnings Per Share	$24.39	$69.75	-$8.48
COMMON SHARES
Basic Shares Outstanding	82.49M shares	82.28M shares	83.04M shares
Diluted Shares Outstanding	84.75M shares	82.65M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$2.100B	$1.779B	$4.298B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$63.34B	$65.83B	$64.68B
YoY Change	-3.87%	-3.78%	-11.17%
Other Assets	$681.0M	$755.0M	$385.0M
YoY Change	-30.58%	-43.78%	-59.64%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$327.0B	$315.0B	$311.1B
YoY Change	3.41%	-10.68%	-17.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$498.0M	$545.0M	$689.0M
YoY Change	-19.81%	3.81%	-24.53%
LONG-TERM LIABILITIES
Long-Term Debt	$2.633B	$2.632B	$2.635B
YoY Change	-0.04%	-0.3%	-0.53%
Other Long-Term Liabilities	$5.916B	$6.053B	$6.200B
YoY Change	11.85%	26.61%	55.58%
Total Long-Term Liabilities	$8.549B	$8.685B	$8.835B
YoY Change	7.9%	17.03%	33.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$498.0M	$545.0M	$689.0M
Total Long-Term Liabilities	$8.549B	$8.685B	$8.835B
Total Liabilities	$317.6B	$305.6B	$301.9B
YoY Change	3.81%	-10.73%	-17.15%
SHAREHOLDERS EQUITY
Retained Earnings	$5.952B	$6.403B	$8.283B
YoY Change	-22.04%	33.9%	194.87%
Common Stock	$1.000M	$1.000M	$1.000M
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$510.0M	$443.0M
YoY Change		45.3%	109.95%
Treasury Stock Shares		13.43M shares	11.78M shares
Shareholders Equity	$8.652B	$8.638B	$8.423B
YoY Change
Total Liabilities & Shareholders Equity	$327.0B	$315.0B	$311.1B
YoY Change	3.41%	-10.68%	-17.16%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q4
OPERATING ACTIVITIES
Net Income	$2.194B	$6.186B	-$710.0M
YoY Change	-24.42%	205.48%	-221.31%
Depreciation, Depletion And Amortization	$317.0M	$1.226B
YoY Change	10466.67%	40766.67%
Cash From Operating Activities	$1.086B	$5.206B	$2.265B
YoY Change	-12.14%	505.35%	4.55%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$78.00M	-$282.0M	-$3.843B
YoY Change	-97.23%	-1009.68%	100.15%
Cash From Investing Activities	$78.00M	-$2.882B	-$3.843B
YoY Change	-97.23%	1326.73%	100.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$0.00
YoY Change
Cash From Financing Activities	-842.0M	-$1.099B	538.0M
YoY Change	-42.6%	80.46%	-652.36%
NET CHANGE
Cash From Operating Activities	1.086B	$5.206B	2.265B
Cash From Investing Activities	78.00M	-$2.882B	-3.843B
Cash From Financing Activities	-842.0M	-$1.099B	538.0M
Net Change In Cash	322.0M	-$2.520B	-1.040B
YoY Change	-87.55%	-5242.86%	-798.46%
FREE CASH FLOW
Cash From Operating Activities	$1.086B	$5.206B	$2.265B
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001822993
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-40274
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Jackson Financial Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0486152
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1 Corporate Way
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Lansing
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MI
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	48951
CY2023Q1	dei	City Area Code CityAreaCode	517
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	381-5500
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	82490622	shares
CY2023Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	29000000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	23000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	49026000000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	48798000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	43774000000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	42489000000	usd
CY2023Q1	jxn	Debt Securities Fair Value Option DebtSecuritiesFairValueOption	2255000000	usd
CY2022Q4	jxn	Debt Securities Fair Value Option DebtSecuritiesFairValueOption	2173000000	usd
CY2023Q1	us-gaap	Trading Securities Debt TradingSecuritiesDebt	101000000	usd
CY2022Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	100000000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	225000000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	393000000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	146000000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	95000000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	10911000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	10967000000	usd
CY2023Q1	jxn	Financing Receivable Fair Value Option FinancingReceivableFairValueOption	480000000	usd
CY2022Q4	jxn	Financing Receivable Fair Value Option FinancingReceivableFairValueOption	582000000	usd
CY2023Q1	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3427000000	usd
CY2022Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3419000000	usd
CY2023Q1	us-gaap	Derivative Assets DerivativeAssets	1051000000	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	1270000000	usd
CY2023Q1	us-gaap	Other Investments OtherInvestments	3711000000	usd
CY2022Q4	us-gaap	Other Investments OtherInvestments	3595000000	usd
CY2023Q1	us-gaap	Investments Investments	66885000000	usd
CY2022Q4	us-gaap	Investments Investments	65946000000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1779000000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4298000000	usd
CY2023Q1	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	497000000	usd
CY2022Q4	us-gaap	Separate Account Assets SeparateAccountAssets	195906000000	usd
CY2022Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	514000000	usd
CY2023Q1	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	12760000000	usd
CY2022Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	12923000000	usd
CY2023Q1	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	15000000	usd
CY2022Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	15000000	usd
CY2023Q1	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	28078000000	usd
CY2022Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	29046000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Reinsurance Recoverable After Allowance MarketRiskBenefitReinsuranceRecoverableAfterAllowance	238000000	usd
CY2022Q4	us-gaap	Market Risk Benefit Reinsurance Recoverable After Allowance MarketRiskBenefitReinsuranceRecoverableAfterAllowance	221000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	5204000000	usd
CY2022Q4	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	4865000000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	755000000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	320000000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	902000000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	944000000	usd
CY2023Q1	us-gaap	Separate Account Assets SeparateAccountAssets	204366000000	usd
CY2023Q1	us-gaap	Assets Assets	321464000000	usd
CY2022Q4	us-gaap	Assets Assets	314983000000	usd
CY2023Q1	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	12369000000	usd
CY2022Q4	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	12318000000	usd
CY2023Q1	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	57094000000	usd
CY2022Q4	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	58190000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	5560000000	usd
CY2022Q4	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	5662000000	usd
CY2023Q1	jxn	Funds Held Under Reinsurance Agreements Fair Value Option FundsHeldUnderReinsuranceAgreementsFairValueOption	3591000000	usd
CY2022Q4	jxn	Funds Held Under Reinsurance Agreements Fair Value Option FundsHeldUnderReinsuranceAgreementsFairValueOption	3582000000	usd
CY2023Q1	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	22254000000	usd
CY2022Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	22957000000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	2632000000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	2635000000	usd
CY2023Q1	jxn	Securities Sold Under Agreements To Repurchase And Securities Loaned SecuritiesSoldUnderAgreementsToRepurchaseAndSecuritiesLoaned	1124000000	usd
CY2022Q4	jxn	Securities Sold Under Agreements To Repurchase And Securities Loaned SecuritiesSoldUnderAgreementsToRepurchaseAndSecuritiesLoaned	1048000000	usd
CY2023Q1	us-gaap	Obligation To Return Securities Received As Collateral ObligationToReturnSecuritiesReceivedAsCollateral	545000000	usd
CY2022Q4	us-gaap	Obligation To Return Securities Received As Collateral ObligationToReturnSecuritiesReceivedAsCollateral	689000000	usd
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	1510000000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2065000000	usd
CY2023Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	2016000000	usd
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	1732000000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	2527000000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	2403000000	usd
CY2023Q1	us-gaap	Separate Accounts Liability SeparateAccountsLiability	204366000000	usd
CY2022Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	195906000000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	311997000000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	305605000000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	24000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	22000	shares
CY2023Q1	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	25000
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	533000000	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81044318	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81044318	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82690098	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82690098	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	1000000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6070000000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6063000000	usd
CY2023Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	13431514	shares
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	11784813	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	510000000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	443000000	usd
CY2023Q1	us-gaap	Aoci Tax Attributable To Parent AociTaxAttributableToParent	52000000	usd
CY2022Q4	us-gaap	Aoci Tax Attributable To Parent AociTaxAttributableToParent	-66000000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2308000000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3378000000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4852000000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6403000000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	8638000000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	8646000000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	829000000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	732000000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9467000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9378000000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	321464000000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	314983000000	usd
CY2023Q1	us-gaap-supplement	Fee Income FeeIncome	1888000000	usd
CY2022Q1	us-gaap-supplement	Fee Income FeeIncome	2012000000	usd
CY2023Q1	us-gaap	Premiums Earned Net PremiumsEarnedNet	25000000	usd
CY2022Q1	us-gaap	Premiums Earned Net PremiumsEarnedNet	37000000	usd
CY2023Q1	jxn	Net Investment Income Excluding Funds Withheld Assets NetInvestmentIncomeExcludingFundsWithheldAssets	415000000	usd
CY2022Q1	jxn	Net Investment Income Excluding Funds Withheld Assets NetInvestmentIncomeExcludingFundsWithheldAssets	430000000	usd
CY2023Q1	jxn	Net Investment Income Funds Withheld Assets NetInvestmentIncomeFundsWithheldAssets	307000000	usd
CY2022Q1	jxn	Net Investment Income Funds Withheld Assets NetInvestmentIncomeFundsWithheldAssets	260000000	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	722000000	usd
CY2022Q1	us-gaap	Net Investment Income NetInvestmentIncome	690000000	usd
CY2023Q1	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-2726000000	usd
CY2022Q1	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-1566000000	usd
CY2023Q1	jxn	Gain Loss On Funds Withheld Reinsurance Treaties GainLossOnFundsWithheldReinsuranceTreaties	-673000000	usd
CY2022Q1	jxn	Gain Loss On Funds Withheld Reinsurance Treaties GainLossOnFundsWithheldReinsuranceTreaties	1028000000	usd
CY2023Q1	jxn	Gain Loss On Investments And Derivative Instruments Net GainLossOnInvestmentsAndDerivativeInstrumentsNet	-3399000000	usd
CY2022Q1	jxn	Gain Loss On Investments And Derivative Instruments Net GainLossOnInvestmentsAndDerivativeInstrumentsNet	-538000000	usd
CY2023Q1	us-gaap	Other Income OtherIncome	15000000	usd
CY2022Q1	us-gaap	Other Income OtherIncome	20000000	usd
CY2023Q1	us-gaap	Revenues Revenues	-749000000	usd
CY2022Q1	us-gaap	Revenues Revenues	2221000000	usd
CY2023Q1	jxn	Death Other Policy Benefits And Change In Policy Reserves Net Of Deferrals DeathOtherPolicyBenefitsAndChangeInPolicyReservesNetOfDeferrals	228000000	usd
CY2022Q1	jxn	Death Other Policy Benefits And Change In Policy Reserves Net Of Deferrals DeathOtherPolicyBenefitsAndChangeInPolicyReservesNetOfDeferrals	300000000	usd
CY2023Q1	us-gaap	Liability For Future Policy Benefit Remeasurement Gain Loss LiabilityForFuturePolicyBenefitRemeasurementGainLoss	-14000000	usd
CY2022Q1	us-gaap	Liability For Future Policy Benefit Remeasurement Gain Loss LiabilityForFuturePolicyBenefitRemeasurementGainLoss	-15000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	174000000	usd
CY2022Q1	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	1907000000	usd
CY2023Q1	us-gaap	Interest Credited To Policyholders Account Balances InterestCreditedToPolicyholdersAccountBalances	285000000	usd
CY2022Q1	us-gaap	Interest Credited To Policyholders Account Balances InterestCreditedToPolicyholdersAccountBalances	197000000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	43000000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	20000000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	616000000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	666000000	usd
CY2023Q1	jxn	Expense Income From Amortization Of Deferred Acquisition Costs ExpenseIncomeFromAmortizationOfDeferredAcquisitionCosts	293000000	usd
CY2022Q1	jxn	Expense Income From Amortization Of Deferred Acquisition Costs ExpenseIncomeFromAmortizationOfDeferredAcquisitionCosts	317000000	usd
CY2023Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	1305000000	usd
CY2022Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	-392000000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2054000000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2613000000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-558000000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	388000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1496000000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	2225000000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	31000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1497000000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2194000000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-18.11
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	25.41
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-18.11
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	24.39
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1496000000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	2225000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	92000000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-777000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	968000000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2826000000	usd
CY2023Q1	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentTax	-2000000	usd
CY2022Q1	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentTax	4000000	usd
CY2023Q1	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment And Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentAndTax	-8000000	usd
CY2022Q1	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment And Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentAndTax	14000000	usd
CY2023Q1	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentTax	-32000000	usd
CY2022Q1	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentTax	166000000	usd
CY2023Q1	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment And Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax	-114000000	usd
CY2022Q1	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment And Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax	599000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	60000000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	202000000	usd
CY2023Q1	us-gaap	Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments Tax OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsTax	-224000000	usd
CY2022Q1	us-gaap	Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments Tax OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsTax	-734000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1070000000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1479000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-426000000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	746000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1000000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	31000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-427000000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	715000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9378000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1496000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1070000000	usd
CY2023Q1	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	96000000	usd
CY2023Q1	us-gaap	Dividends Dividends	54000000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	70000000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	533000000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10000000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9467000000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8321000000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	2225000000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1479000000	usd
CY2022Q1	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	4000000	usd
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	140000000	usd
CY2022Q1	us-gaap	Dividends Dividends	52000000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	30000000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8909000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1496000000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	2225000000	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-68000000	usd
CY2022Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-130000000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-2658000000	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1436000000	usd
CY2023Q1	jxn	Net Gains Losses On Funds Withheld Payable Under Reinsurance Treaties NetGainsLossesOnFundsWithheldPayableUnderReinsuranceTreaties	-673000000	usd
CY2022Q1	jxn	Net Gains Losses On Funds Withheld Payable Under Reinsurance Treaties NetGainsLossesOnFundsWithheldPayableUnderReinsuranceTreaties	1028000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	174000000	usd
CY2022Q1	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	1907000000	usd
CY2023Q1	us-gaap	Liability For Future Policy Benefit Remeasurement Gain Loss LiabilityForFuturePolicyBenefitRemeasurementGainLoss	-14000000	usd
CY2022Q1	us-gaap	Liability For Future Policy Benefit Remeasurement Gain Loss LiabilityForFuturePolicyBenefitRemeasurementGainLoss	-15000000	usd
CY2023Q1	us-gaap	Interest Credited To Policy Owner Account InterestCreditedToPolicyOwnerAccount	285000000	usd
CY2022Q1	us-gaap	Interest Credited To Policy Owner Account InterestCreditedToPolicyOwnerAccount	197000000	usd
CY2023Q1	jxn	Mortality Expense And Surrender Charges MortalityExpenseAndSurrenderCharges	132000000	usd
CY2022Q1	jxn	Mortality Expense And Surrender Charges MortalityExpenseAndSurrenderCharges	135000000	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	6000000	usd
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-8000000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-553000000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	411000000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	24000000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	71000000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-17000000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-18000000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	-163000000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	-137000000	usd
CY2023Q1	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	-75000000	usd
CY2022Q1	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	-55000000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	155000000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	800000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1461000000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	833000000	usd
CY2023Q1	jxn	Proceeds From Sale And Maturity Of Debt Securities ProceedsFromSaleAndMaturityOfDebtSecurities	2931000000	usd
CY2022Q1	jxn	Proceeds From Sale And Maturity Of Debt Securities ProceedsFromSaleAndMaturityOfDebtSecurities	4953000000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	157000000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	6000000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Collection Of Finance Receivables ProceedsFromSaleAndCollectionOfFinanceReceivables	469000000	usd
CY2022Q1	us-gaap	Proceeds From Sale And Collection Of Finance Receivables ProceedsFromSaleAndCollectionOfFinanceReceivables	315000000	usd
CY2023Q1	jxn	Payments To Acquire Debt Securities PaymentsToAcquireDebtSecurities	3325000000	usd
CY2022Q1	jxn	Payments To Acquire Debt Securities PaymentsToAcquireDebtSecurities	4042000000	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	2000000	usd
CY2022Q1	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	1000000	usd
CY2023Q1	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	348000000	usd
CY2022Q1	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	452000000	usd
CY2023Q1	jxn	Payments For Proceeds From Derivative Instruments And Collateral On Investments PaymentsForProceedsFromDerivativeInstrumentsAndCollateralOnInvestments	3046000000	usd
CY2022Q1	jxn	Payments For Proceeds From Derivative Instruments And Collateral On Investments PaymentsForProceedsFromDerivativeInstrumentsAndCollateralOnInvestments	950000000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-282000000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	31000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2882000000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-202000000	usd
CY2023Q1	us-gaap	Additions To Contract Holders Funds AdditionsToContractHoldersFunds	3874000000	usd
CY2022Q1	us-gaap	Additions To Contract Holders Funds AdditionsToContractHoldersFunds	5857000000	usd
CY2023Q1	us-gaap	Withdrawal From Contract Holders Funds WithdrawalFromContractHoldersFunds	7517000000	usd
CY2022Q1	us-gaap	Withdrawal From Contract Holders Funds WithdrawalFromContractHoldersFunds	6700000000	usd
CY2023Q1	jxn	Transfers To From Separate Accounts TransfersToFromSeparateAccounts	2060000000	usd
CY2022Q1	jxn	Transfers To From Separate Accounts TransfersToFromSeparateAccounts	951000000	usd
CY2023Q1	us-gaap	Proceeds From Payments For In Securities Sold Under Agreements To Repurchase ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase	76000000	usd
CY2022Q1	us-gaap	Proceeds From Payments For In Securities Sold Under Agreements To Repurchase ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase	-990000000	usd
CY2023Q1	jxn	Payments Of Proceeds From Fhl Bank Borrowings Financing Activities PaymentsOfProceedsFromFHLBankBorrowingsFinancingActivities	0	usd
CY2022Q1	jxn	Payments Of Proceeds From Fhl Bank Borrowings Financing Activities PaymentsOfProceedsFromFHLBankBorrowingsFinancingActivities	-500000000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	-4000000	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	-8000000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	51000000	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	52000000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	70000000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	140000000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	533000000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1099000000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-582000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2520000000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	49000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4301000000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2631000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1781000000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2680000000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	21000000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	9000000	usd
CY2023Q1	jxn	Debt Securities Acquired From Noncash Transactions DebtSecuritiesAcquiredFromNoncashTransactions	32000000	usd
CY2022Q1	jxn	Debt Securities Acquired From Noncash Transactions DebtSecuritiesAcquiredFromNoncashTransactions	112000000	usd
CY2023Q1	jxn	Other Invested Assets Acquired From Stock Splits And Stock Distributions OtherInvestedAssetsAcquiredFromStockSplitsAndStockDistributions	9000000	usd
CY2022Q1	jxn	Other Invested Assets Acquired From Stock Splits And Stock Distributions OtherInvestedAssetsAcquiredFromStockSplitsAndStockDistributions	32000000	usd
CY2023Q1	jxn	Non Cash Dividend Equivalents On Stock Based Awards NonCashDividendEquivalentsOnStockBasedAwards	3000000	usd
CY2022Q1	jxn	Non Cash Dividend Equivalents On Stock Based Awards NonCashDividendEquivalentsOnStockBasedAwards	0	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1779000000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2674000000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	2000000	usd
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	6000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1781000000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2680000000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires the use of estimates and assumptions about future events that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. Significant estimates or assumptions, as further discussed in the notes, include:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Valuation of investments and derivative instruments, including fair values of securities deemed to be in an illiquid market and the determination of when an impairment is necessary;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assessments as to whether certain entities are VIEs, the existence of reconsideration events and the determination of which party, if any, should consolidate the entity;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumptions used in calculating policy reserves and liabilities including policyholder behavior, mortality rates, expenses, investment returns and policy crediting rates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumptions as to future earnings levels being sufficient to realize deferred tax benefits;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Estimates related to expectations of credit losses on certain financial assets and off-balance sheet exposures;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumptions and estimates associated with the Company’s tax positions, including an estimate of the dividends received deduction, which impact the amount of recognized tax benefits recorded by the Company;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumptions used in calculating market risk benefits including policyholder behavior, mortality rates, and capital market assumptions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumptions impacting the expected term used in the calculation of amortization of deferred acquisition costs, including policyholder behavior and mortality rates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates and assumptions are based on management’s best estimates and judgments. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors deemed appropriate. As facts and circumstances dictate, these estimates and assumptions may be adjusted. Since future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in estimates, including those resulting from continuing changes in the economic environment, will be reflected in the consolidated financial statements in the periods the estimates are changed.</span></div>
CY2023Q1	us-gaap	Comparability Of Prior Year Financial Data ComparabilityOfPriorYearFinancialData	In 2022, the Company identified errors related to the classification of certain balances and amounts in the line items of the Condensed Consolidated Balance Sheets and Condensed Consolidated Income Statements. These errors resulted in the revision of balances and amounts related to deferred sales inducement assets, liabilities for certain life-contingent annuities, sub-advisor fee expenses, and other operating expense items that impacted previously issued Condensed Consolidated Financial Statements. The impact of these errors to the prior periods' Condensed Consolidated Financial Statements were not considered to be material and had no impact on shareholders' equity or net income (loss). However, to improve the consistency and comparability of the financial statements, management revised the financial statements and related disclosures in this quarterly report. See Note 22 to the Notes to Condensed Consolidated Financial Statements for details of the revisions.
CY2021Q1	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	14043000000	usd
CY2021Q1	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	35116000000	usd
CY2021Q1	us-gaap	Market Risk Benefit Reinsurance Recoverable After Allowance MarketRiskBenefitReinsuranceRecoverableAfterAllowance	471000000	usd
CY2021Q1	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	690000000	usd
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1882000000	usd
CY2021Q1	us-gaap	Other Assets OtherAssets	1181000000	usd
CY2021Q1	us-gaap	Assets Assets	355511000000	usd
CY2021Q1	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	16796000000	usd
CY2021Q1	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	63585000000	usd
CY2021Q1	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	10690000000	usd
CY2021Q1	us-gaap	Liabilities Liabilities	348576000000	usd
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3436000000	usd
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2927000000	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6935000000	usd
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	355511000000	usd
CY2021Q1	jxn	Liability For Future Policy Benefit Expected Future Policy Benefit Before Other Future Policy Benefits And Claims Payable LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeOtherFuturePolicyBenefitsAndClaimsPayable	14022000000	usd
CY2020Q4	us-gaap	Liability For Future Policy Benefit After Reinsurance LiabilityForFuturePolicyBenefitAfterReinsurance	16796000000	usd
CY2021Q1	us-gaap	Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk	10000000000	usd
CY2021Q1	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	14043000000	usd
CY2021Q1	us-gaap	Liability For Future Policy Benefit Reinsurance Recoverable After Allowance LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance	35116000000	usd
CY2021Q1	us-gaap	Market Risk Benefit Reinsurance Recoverable After Allowance MarketRiskBenefitReinsuranceRecoverableAfterAllowance	471000000	usd
CY2023Q1	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	12923000000	usd
CY2023Q1	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	29046000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Reinsurance Recoverable After Allowance MarketRiskBenefitReinsuranceRecoverableAfterAllowance	221000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	4865000000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	320000000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	944000000	usd
CY2023Q1	us-gaap	Assets Assets	314983000000	usd
CY2023Q1	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	12318000000	usd
CY2023Q1	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	58190000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	5662000000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	305605000000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3378000000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6403000000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9378000000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	314983000000	usd
CY2023Q2	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-538000000	usd
CY2023Q2	us-gaap	Revenues Revenues	2221000000	usd
CY2023Q2	jxn	Death Other Policy Benefits And Change In Policy Reserves Net Of Deferrals DeathOtherPolicyBenefitsAndChangeInPolicyReservesNetOfDeferrals	300000000	usd
CY2023Q2	us-gaap	Liability For Future Policy Benefit Remeasurement Gain Loss LiabilityForFuturePolicyBenefitRemeasurementGainLoss	-15000000	usd
CY2023Q2	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	1907000000	usd
CY2023Q2	us-gaap	Interest Credited To Policyholders Account Balances InterestCreditedToPolicyholdersAccountBalances	197000000	usd
CY2023Q2	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	317000000	usd
CY2023Q2	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	-392000000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2613000000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	388000000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	2225000000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	2194000000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	25.41
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	24.39
CY2022Q1	us-gaap	Profit Loss ProfitLoss	2225000000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2826000000	usd
CY2022Q1	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment And Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax	599000000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-734000000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1479000000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	715000000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	2225000000	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1436000000	usd
CY2022Q1	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	1907000000	usd
CY2022Q1	us-gaap	Liability For Future Policy Benefit Remeasurement Gain Loss LiabilityForFuturePolicyBenefitRemeasurementGainLoss	-15000000	usd
CY2022Q1	us-gaap	Interest Credited To Policy Owner Account InterestCreditedToPolicyOwnerAccount	197000000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	411000000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	-137000000	usd
CY2022Q1	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	-55000000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	800000000	usd
CY2022Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-456000000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	833000000	usd
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q1	jxn	Securities Loaned Minimum Fair Value Collateral Percent SecuritiesLoanedMinimumFairValueCollateralPercent	1.02
CY2023Q1	us-gaap	Revenues Revenues	-749000000	usd
CY2022Q1	us-gaap	Revenues Revenues	2221000000	usd
CY2023Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	1305000000	usd
CY2022Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	-392000000	usd
CY2023Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-2055000000	usd
CY2022Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	2582000000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-558000000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	388000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1497000000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2194000000	usd
CY2023Q1	jxn	Debt Securities Rated DebtSecuritiesRated	492000000	usd
CY2022Q4	jxn	Debt Securities Rated DebtSecuritiesRated	32000000	usd
CY2023Q1	jxn	Debt Securities Percentage DebtSecuritiesPercentage	1.000
CY2022Q4	jxn	Debt Securities Percentage DebtSecuritiesPercentage	1.000
CY2023Q1	jxn	Debt Securities Amortized Cost DebtSecuritiesAmortizedCost	51382000000	usd
CY2023Q1	jxn	Debt Securities Allowance For Credit Loss DebtSecuritiesAllowanceForCreditLoss	29000000	usd
CY2023Q1	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	176000000	usd
CY2023Q1	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	5399000000	usd
CY2023Q1	us-gaap	Debt Securities DebtSecurities	46130000000	usd
CY2022Q4	jxn	Debt Securities Amortized Cost DebtSecuritiesAmortizedCost	51071000000	usd
CY2022Q4	jxn	Debt Securities Allowance For Credit Loss DebtSecuritiesAllowanceForCreditLoss	23000000	usd
CY2022Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	115000000	usd
CY2022Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	6401000000	usd
CY2022Q4	us-gaap	Debt Securities DebtSecurities	44762000000	usd
CY2023Q1	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateYearOne	2165000000	usd
CY2023Q1	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateYearOne	1000000	usd
CY2023Q1	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateYearOne	0	usd
CY2023Q1	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateYearOne	9000000	usd
CY2023Q1	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date Year One DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateYearOne	2155000000	usd
CY2023Q1	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year One Through Five DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive	10263000000	usd
CY2023Q1	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year One Through Five DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive	2000000	usd
CY2023Q1	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year One Through Year Five DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughYearFive	19000000	usd
CY2023Q1	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year One Through Year Five DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughYearFive	369000000	usd
CY2023Q1	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year One Through Five DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive	9911000000	usd
CY2023Q1	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year Five Through Ten DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughTen	14000000000	usd
CY2023Q1	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year Five Through Ten DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughTen	4000000	usd
CY2023Q1	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year Five Through Year Ten DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughYearTen	60000000	usd
CY2023Q1	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year Five Through Year Ten DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughYearTen	1279000000	usd
CY2023Q1	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year Five Through Ten DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughTen	12777000000	usd
CY2023Q1	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year Ten Through Twenty DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughTwenty	8980000000	usd
CY2023Q1	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year Ten Through Twenty DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughTwenty	3000000	usd
CY2023Q1	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year Ten Through Year Twenty DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughYearTwenty	66000000	usd
CY2023Q1	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year Ten Through Year Twenty DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughYearTwenty	1335000000	usd
CY2023Q1	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year Ten Through Twenty DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughTwenty	7708000000	usd
CY2023Q1	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	7766000000	usd
CY2023Q1	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	14000000	usd
CY2023Q1	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	8000000	usd
CY2023Q1	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	1755000000	usd
CY2023Q1	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	6005000000	usd
CY2023Q1	jxn	Debt Securities Amortized Cost DebtSecuritiesAmortizedCost	51382000000	usd
CY2023Q1	jxn	Debt Securities Allowance For Credit Loss DebtSecuritiesAllowanceForCreditLoss	29000000	usd
CY2023Q1	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	176000000	usd
CY2023Q1	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	5399000000	usd
CY2023Q1	us-gaap	Debt Securities DebtSecurities	46130000000	usd
CY2023Q1	us-gaap	Securities Reserve Deposit Required And Made SecuritiesReserveDepositRequiredAndMade	94000000	usd
CY2022Q4	us-gaap	Securities Reserve Deposit Required And Made SecuritiesReserveDepositRequiredAndMade	90000000	usd
CY2023Q1	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1034000000	usd
CY2023Q1	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesContinuousUnrealizedLossPositionLessThan12Months	17319000000	usd
CY2023Q1	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	2063	security
CY2022Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	3571000000	usd
CY2022Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesContinuousUnrealizedLossPositionLessThan12Months	30605000000	usd
CY2022Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	3786	security
CY2023Q1	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	4365000000	usd
CY2023Q1	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLonger	20400000000	usd
CY2023Q1	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	2596	security
CY2022Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	2830000000	usd
CY2022Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLonger	8508000000	usd
CY2022Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	1056	security
CY2023Q1	jxn	Debt Securities Unrealized Loss Position Accumulated Loss DebtSecuritiesUnrealizedLossPositionAccumulatedLoss	5399000000	usd
CY2023Q1	jxn	Debt Securities Unrealized Loss Position DebtSecuritiesUnrealizedLossPosition	37719000000	usd
CY2023Q1	jxn	Debt Securities Unrealized Loss Position Number Of Positions DebtSecuritiesUnrealizedLossPositionNumberOfPositions	4417	security
CY2022Q4	jxn	Debt Securities Unrealized Loss Position Accumulated Loss DebtSecuritiesUnrealizedLossPositionAccumulatedLoss	6401000000	usd
CY2022Q4	jxn	Debt Securities Unrealized Loss Position DebtSecuritiesUnrealizedLossPosition	39113000000	usd
CY2022Q4	jxn	Debt Securities Unrealized Loss Position Number Of Positions DebtSecuritiesUnrealizedLossPositionNumberOfPositions	4645	security
CY2023Q1	jxn	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List Not Disclosed Flag DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleListNotDisclosedFlag	Accrued interest receivable
CY2023Q1	jxn	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List Not Disclosed Flag DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleListNotDisclosedFlag	Accrued interest receivable
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	23000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded	32000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal	1000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date DebtSecuritiesAvailableForSaleExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate	0	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff	0	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSecuritiesSold	10000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Sell Before Recovery DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSellBeforeRecovery	17000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	29000000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	9000000	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded	33000000	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal	-5000000	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date DebtSecuritiesAvailableForSaleExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate	0	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff	0	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSecuritiesSold	0	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Sell Before Recovery DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSellBeforeRecovery	5000000	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	32000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	413000000	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	385000000	usd
CY2023Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	115000000	usd
CY2022Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	43000000	usd
CY2023Q1	jxn	Net Investment Income Excluding Funds Withheld Assets NetInvestmentIncomeExcludingFundsWithheldAssets	415000000	usd
CY2022Q1	jxn	Net Investment Income Excluding Funds Withheld Assets NetInvestmentIncomeExcludingFundsWithheldAssets	430000000	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	722000000	usd
CY2022Q1	us-gaap	Net Investment Income NetInvestmentIncome	690000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	4000000	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	24000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	25000000	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	178000000	usd
CY2023Q1	jxn	Debt Securities Available For Sale Credit Loss Expense Reversal DebtSecuritiesAvailableForSaleCreditLossExpenseReversal	11000000	usd
CY2022Q1	jxn	Debt Securities Available For Sale Credit Loss Expense Reversal DebtSecuritiesAvailableForSaleCreditLossExpenseReversal	0	usd
CY2023Q1	jxn	Financing Receivable Credit Loss Expense Reversal And Other Gain Loss FinancingReceivableCreditLossExpenseReversalAndOtherGainLoss	47000000	usd
CY2022Q1	jxn	Financing Receivable Credit Loss Expense Reversal And Other Gain Loss FinancingReceivableCreditLossExpenseReversalAndOtherGainLoss	-12000000	usd
CY2023Q1	jxn	Other Operating Gain Loss OtherOperatingGainLoss	11000000	usd
CY2022Q1	jxn	Other Operating Gain Loss OtherOperatingGainLoss	12000000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-68000000	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-130000000	usd
CY2023Q1	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-2726000000	usd
CY2022Q1	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-1566000000	usd
CY2023Q1	jxn	Gain Loss On Investments And Derivative Instruments Net GainLossOnInvestmentsAndDerivativeInstrumentsNet	-3399000000	usd
CY2022Q1	jxn	Gain Loss On Investments And Derivative Instruments Net GainLossOnInvestmentsAndDerivativeInstrumentsNet	-538000000	usd
CY2023Q1	jxn	Aggregate Fair Value Of Securities Sold At A Loss AggregateFairValueOfSecuritiesSoldAtALoss	1797000000	usd
CY2022Q1	jxn	Aggregate Fair Value Of Securities Sold At A Loss AggregateFairValueOfSecuritiesSoldAtALoss	2392000000	usd
CY2023Q1	jxn	Aggregate Fair Value Of Securities Sold At A Loss Percentage Of Book Value AggregateFairValueOfSecuritiesSoldAtALossPercentageOfBookValue	0.97
CY2022Q1	jxn	Aggregate Fair Value Of Securities Sold At A Loss Percentage Of Book Value AggregateFairValueOfSecuritiesSoldAtALossPercentageOfBookValue	0.92
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2100000000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	4000000000.0	usd
CY2023Q1	us-gaap	Secured Debt SecuredDebt	276000000	usd
CY2023Q1	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	3379000000	usd
CY2022Q4	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	3285000000	usd
CY2023Q1	jxn	Interest And Principal Payment Deferral Repayment Period Covid19 InterestAndPrincipalPaymentDeferralRepaymentPeriodCOVID19	P1Y
CY2023Q1	jxn	Deferred Interest And Principal Payment Amount Covid19 DeferredInterestAndPrincipalPaymentAmountCOVID19	10000000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	95000000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	0	usd
CY2023Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	51000000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	146000000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	94000000	usd
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	0	usd
CY2022Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-10000000	usd
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	84000000	usd
CY2023Q1	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	47000000	usd
CY2022Q1	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	44000000	usd
CY2023Q1	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	15000000	usd
CY2023Q1	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	16000000	usd
CY2023Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	16000000	usd
CY2023Q1	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	0	usd
CY2022Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	15000000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	16000000	usd
CY2022	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	18000000	usd
CY2022	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	0	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	256000000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	1228000000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	1875000000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	1185000000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	1496000000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	5347000000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Revolving FinancingReceivableExcludingAccruedInterestRevolving	4000000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	11391000000	usd
CY2023Q1	srt	Financing Receivable Before Allowance For Credit Loss To Total Percent FinancingReceivableBeforeAllowanceForCreditLossToTotalPercent	1
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	1315000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	1927000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	1260000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	1554000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	1511000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	3978000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Revolving FinancingReceivableExcludingAccruedInterestRevolving	4000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	11549000000	usd
CY2022Q4	srt	Financing Receivable Before Allowance For Credit Loss To Total Percent FinancingReceivableBeforeAllowanceForCreditLossToTotalPercent	1
CY2023Q1	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	0	usd
CY2023Q1	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	15000000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	11391000000	usd
CY2022Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	0	usd
CY2022Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	15000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	11549000000	usd
CY2023Q1	jxn	Financing Receivable Stressed Loans FinancingReceivableStressedLoans	4000000	usd
CY2022Q4	jxn	Financing Receivable Stressed Loans FinancingReceivableStressedLoans	3	usd
CY2023Q1	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3400000000	usd
CY2023Q1	jxn	Loans Gross Insurance Policy Not Held As Collateral LoansGrossInsurancePolicyNotHeldAsCollateral	1000000000.0	usd
CY2022Q4	jxn	Loans Gross Insurance Policy Not Held As Collateral LoansGrossInsurancePolicyNotHeldAsCollateral	1000000000.0	usd
	us-gaap	Proceeds From Limited Partnership Investments ProceedsFromLimitedPartnershipInvestments	420000000	usd
CY2021Q2	us-gaap	Proceeds From Limited Partnership Investments ProceedsFromLimitedPartnershipInvestments	236000000	usd
CY2021Q3	us-gaap	Proceeds From Limited Partnership Investments ProceedsFromLimitedPartnershipInvestments	168000000	usd
CY2023Q1	jxn	Securities Loaned Fair Value Disclosure SecuritiesLoanedFairValueDisclosure	38000000	usd
CY2022Q4	jxn	Securities Loaned Fair Value Disclosure SecuritiesLoanedFairValueDisclosure	35000000	usd
CY2022Q4	jxn	Derivative Liabilities By Counterparty DerivativeLiabilitiesByCounterparty	1680000000	usd
CY2023Q1	us-gaap	Securities Loaned Fair Value Of Collateral SecuritiesLoanedFairValueOfCollateral	39000000	usd
CY2022Q4	us-gaap	Securities Loaned Fair Value Of Collateral SecuritiesLoanedFairValueOfCollateral	36000000	usd
CY2023Q1	srt	Securities Sold Under Agreements To Repurchase Average Rate Paid SecuritiesSoldUnderAgreementsToRepurchaseAverageRatePaid	0.0387
CY2022	srt	Securities Sold Under Agreements To Repurchase Average Rate Paid SecuritiesSoldUnderAgreementsToRepurchaseAverageRatePaid	0.0254
CY2023Q1	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	1085000000	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	1012000000	usd
CY2023Q1	jxn	Securities Sold Under Agreements To Repurchase Highest Average Amount Outstanding SecuritiesSoldUnderAgreementsToRepurchaseHighestAverageAmountOutstanding	1085000000	usd
CY2022Q1	jxn	Securities Sold Under Agreements To Repurchase Highest Average Amount Outstanding SecuritiesSoldUnderAgreementsToRepurchaseHighestAverageAmountOutstanding	584000000	usd
CY2023Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-3037000000	usd
CY2022Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-134000000	usd
CY2023Q1	jxn	Derivative Assets By Counterparty DerivativeAssetsByCounterparty	749000000	usd
CY2022Q4	jxn	Derivative Assets By Counterparty DerivativeAssetsByCounterparty	885000000	usd
CY2023Q1	us-gaap	Derivative Asset Fair Value Of Collateral DerivativeAssetFairValueOfCollateral	695000000	usd
CY2022Q4	us-gaap	Derivative Asset Fair Value Of Collateral DerivativeAssetFairValueOfCollateral	858000000	usd
CY2023Q1	jxn	Derivative Liabilities By Counterparty DerivativeLiabilitiesByCounterparty	1208000000	usd
CY2023Q1	us-gaap	Derivative Liability Fair Value Of Collateral DerivativeLiabilityFairValueOfCollateral	1357000000	usd
CY2022Q4	us-gaap	Derivative Liability Fair Value Of Collateral DerivativeLiabilityFairValueOfCollateral	1650000000	usd
CY2023Q1	jxn	Derivative Downgrade Provision Triggered Disbursement Obligation DerivativeDowngradeProvisionTriggeredDisbursementObligation	0	usd
CY2022Q4	jxn	Derivative Downgrade Provision Triggered Disbursement Obligation DerivativeDowngradeProvisionTriggeredDisbursementObligation	30000000	usd
CY2023Q1	jxn	Derivative Claim DerivativeClaim	203000000	usd
CY2022Q4	jxn	Derivative Claim DerivativeClaim	27000000	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	1051000000	usd
CY2023Q1	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2023Q1	us-gaap	Derivative Assets DerivativeAssets	1051000000	usd
CY2023Q1	us-gaap	Derivative Asset Not Offset Policy Election Deduction DerivativeAssetNotOffsetPolicyElectionDeduction	301000000	usd
CY2023Q1	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	532000000	usd
CY2023Q1	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	132000000	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	86000000	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	1510000000	usd
CY2023Q1	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	1510000000	usd
CY2023Q1	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	301000000	usd
CY2023Q1	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	2000000	usd
CY2023Q1	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	1207000000	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	0	usd
CY2023Q1	us-gaap	Securities Loaned Gross SecuritiesLoanedGross	39000000	usd
CY2023Q1	us-gaap	Securities Loaned Asset SecuritiesLoanedAsset	0	usd
CY2023Q1	us-gaap	Securities Loaned SecuritiesLoaned	39000000	usd
CY2023Q1	us-gaap	Securities Loaned Not Offset Policy Election Deduction SecuritiesLoanedNotOffsetPolicyElectionDeduction	0	usd
CY2023Q1	us-gaap	Securities Loaned Collateral Right To Reclaim Cash SecuritiesLoanedCollateralRightToReclaimCash	39000000	usd
CY2023Q1	us-gaap	Securities Loaned Collateral Right To Reclaim Securities SecuritiesLoanedCollateralRightToReclaimSecurities	0	usd
CY2023Q1	us-gaap	Securities Loaned Amount Offset Against Collateral SecuritiesLoanedAmountOffsetAgainstCollateral	0	usd
CY2023Q1	us-gaap	Securities Sold Under Agreements To Repurchase Gross SecuritiesSoldUnderAgreementsToRepurchaseGross	1085000000	usd
CY2023Q1	us-gaap	Securities Sold Under Agreements To Repurchase Asset SecuritiesSoldUnderAgreementsToRepurchaseAsset	0	usd
CY2023Q1	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	1085000000	usd
CY2023Q1	us-gaap	Securities Sold Under Agreements To Resell Not Offset Policy Election Deduction SecuritiesSoldUnderAgreementsToResellNotOffsetPolicyElectionDeduction	0	usd
CY2023Q1	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0	usd
CY2023Q1	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	1085000000	usd
CY2023Q1	us-gaap	Securities Sold Under Agreements To Repurchase Amount Offset Against Collateral SecuritiesSoldUnderAgreementsToRepurchaseAmountOffsetAgainstCollateral	0	usd
CY2023Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross	2634000000	usd
CY2023Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset	0	usd
CY2023Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoaned	2634000000	usd
CY2023Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Offset Policy Election Deduction DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotOffsetPolicyElectionDeduction	301000000	usd
CY2023Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash	41000000	usd
CY2023Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities	2292000000	usd
CY2023Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Offset Against Collateral DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountOffsetAgainstCollateral	0	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	1270000000	usd
CY2022Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	1270000000	usd
CY2022Q4	us-gaap	Derivative Asset Not Offset Policy Election Deduction DerivativeAssetNotOffsetPolicyElectionDeduction	385000000	usd
CY2022Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	683000000	usd
CY2022Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	157000000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	45000000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	2065000000	usd
CY2022Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2065000000	usd
CY2022Q4	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	385000000	usd
CY2022Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2022Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	1638000000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	42000000	usd
CY2022Q4	us-gaap	Securities Loaned Gross SecuritiesLoanedGross	36000000	usd
CY2022Q4	us-gaap	Securities Loaned Asset SecuritiesLoanedAsset	0	usd
CY2022Q4	us-gaap	Securities Loaned SecuritiesLoaned	36000000	usd
CY2022Q4	us-gaap	Securities Loaned Not Offset Policy Election Deduction SecuritiesLoanedNotOffsetPolicyElectionDeduction	0	usd
CY2022Q4	us-gaap	Securities Loaned Collateral Right To Reclaim Cash SecuritiesLoanedCollateralRightToReclaimCash	36000000	usd
CY2022Q4	us-gaap	Securities Loaned Collateral Right To Reclaim Securities SecuritiesLoanedCollateralRightToReclaimSecurities	0	usd
CY2022Q4	us-gaap	Securities Loaned Amount Offset Against Collateral SecuritiesLoanedAmountOffsetAgainstCollateral	0	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Gross SecuritiesSoldUnderAgreementsToRepurchaseGross	1012000000	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Asset SecuritiesSoldUnderAgreementsToRepurchaseAsset	0	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	1012000000	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Resell Not Offset Policy Election Deduction SecuritiesSoldUnderAgreementsToResellNotOffsetPolicyElectionDeduction	0	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	1012000000	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Amount Offset Against Collateral SecuritiesSoldUnderAgreementsToRepurchaseAmountOffsetAgainstCollateral	0	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross	3113000000	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset	0	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoaned	3113000000	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Offset Policy Election Deduction DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotOffsetPolicyElectionDeduction	385000000	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash	36000000	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities	2650000000	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Offset Against Collateral DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountOffsetAgainstCollateral	42000000	usd
CY2023Q1	jxn	Financing Receivable Fair Value Option FinancingReceivableFairValueOption	480000000	usd
CY2022Q4	jxn	Financing Receivable Fair Value Option FinancingReceivableFairValueOption	582000000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	225000000	usd
CY2023Q1	jxn	Financing Receivable Fair Value Option FinancingReceivableFairValueOption	480000000	usd
CY2023Q1	jxn	Investments In Limited Partnerships InvestmentsInLimitedPartnerships	550000000	usd
CY2023Q1	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3427000000	usd
CY2023Q1	us-gaap	Derivative Assets DerivativeAssets	1051000000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	1779000000	usd
CY2023Q1	jxn	Gmib Reinsurance Recoverable GMIBReinsuranceRecoverable	238000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	5204000000	usd
CY2023Q1	us-gaap	Separate Account Assets SeparateAccountAssets	204366000000	usd
CY2023Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	263450000000	usd
CY2023Q1	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	1384000000	usd
CY2023Q1	jxn	Funds Withheld Payable Under Reinsurance Treaties FundsWithheldPayableUnderReinsuranceTreaties	803000000	usd
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	1510000000	usd
CY2023Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	2016000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	5560000000	usd
CY2023Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	11273000000	usd
CY2023Q1	us-gaap	Alternative Investment AlternativeInvestment	2780000000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	393000000	usd
CY2022Q4	jxn	Financing Receivable Fair Value Option FinancingReceivableFairValueOption	582000000	usd
CY2022Q4	jxn	Investments In Limited Partnerships InvestmentsInLimitedPartnerships	440000000	usd
CY2022Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3419000000	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	1270000000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	4298000000	usd
CY2022Q4	jxn	Gmib Reinsurance Recoverable GMIBReinsuranceRecoverable	221000000	usd
CY2022Q4	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	4865000000	usd
CY2022Q4	us-gaap	Separate Account Assets SeparateAccountAssets	195906000000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	256156000000	usd
CY2022Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	1135000000	usd
CY2022Q4	jxn	Funds Withheld Payable Under Reinsurance Treaties FundsWithheldPayableUnderReinsuranceTreaties	424000000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2065000000	usd
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	1732000000	usd
CY2022Q4	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	5662000000	usd
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	11018000000	usd
CY2022Q4	us-gaap	Alternative Investment AlternativeInvestment	2772000000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	55000000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	148000000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	35000000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	56000000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases Sales Issuances Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements	-114000000	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	190000000	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	0	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	30000000	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	85000000	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases Sales Issuances Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements	135000000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	37000000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	11000000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	7000000	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	4000000	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	7000000	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0	usd
CY2023Q1	jxn	Federal Home Loan Bank Capital Stock Share Price FederalHomeLoanBankCapitalStockSharePrice	100
CY2023Q1	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	10911000000	usd
CY2023Q1	jxn	Loans Gross Insurance Policy Excluding At Fair Value Under Fair Value Option LoansGrossInsurancePolicyExcludingAtFairValueUnderFairValueOption	950000000	usd
CY2023Q1	us-gaap	Investment In Federal Home Loan Bank Stock Fair Value Disclosure InvestmentInFederalHomeLoanBankStockFairValueDisclosure	146000000	usd
CY2023Q1	jxn	Liability For Future Policy Benefits Annuity Reserves LiabilityForFuturePolicyBenefitsAnnuityReserves	35256000000	usd
CY2023Q1	us-gaap	Liabilities Related To Investment Contracts Fair Value Disclosure LiabilitiesRelatedToInvestmentContractsFairValueDisclosure	989000000	usd
CY2023Q1	us-gaap	Security Owned And Pledged As Collateral Associated Liabilities Fair Value SecurityOwnedAndPledgedAsCollateralAssociatedLiabilitiesFairValue	5597000000	usd
CY2023Q1	us-gaap	Federal Funds Purchased Fair Value Disclosure FederalFundsPurchasedFairValueDisclosure	2105000000	usd
CY2023Q1	jxn	Funds Held Under Reinsurance Agreements Liability Excluding At Fair Value Under Fair Value Option FundsHeldUnderReinsuranceAgreementsLiabilityExcludingAtFairValueUnderFairValueOption	21451000000	usd
CY2023Q1	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	2632000000	usd
CY2023Q1	us-gaap	Securities Loaned SecuritiesLoaned	39000000	usd
CY2023Q1	us-gaap	Assets Sold Under Agreements To Repurchase Repurchase Liability AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability	1085000000	usd
CY2023Q1	us-gaap	Separate Accounts Liability SeparateAccountsLiability	204366000000	usd
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	10967000000	usd
CY2022Q4	jxn	Loans Gross Insurance Policy Excluding At Fair Value Under Fair Value Option LoansGrossInsurancePolicyExcludingAtFairValueUnderFairValueOption	958000000	usd
CY2022Q4	us-gaap	Investment In Federal Home Loan Bank Stock Fair Value Disclosure InvestmentInFederalHomeLoanBankStockFairValueDisclosure	146000000	usd
CY2022Q4	jxn	Liability For Future Policy Benefits Annuity Reserves LiabilityForFuturePolicyBenefitsAnnuityReserves	36222000000	usd
CY2022Q4	us-gaap	Liabilities Related To Investment Contracts Fair Value Disclosure LiabilitiesRelatedToInvestmentContractsFairValueDisclosure	1128000000	usd
CY2022Q4	us-gaap	Security Owned And Pledged As Collateral Associated Liabilities Fair Value SecurityOwnedAndPledgedAsCollateralAssociatedLiabilitiesFairValue	5887000000	usd
CY2022Q4	us-gaap	Federal Funds Purchased Fair Value Disclosure FederalFundsPurchasedFairValueDisclosure	2004000000	usd
CY2022Q4	jxn	Funds Held Under Reinsurance Agreements Liability Excluding At Fair Value Under Fair Value Option FundsHeldUnderReinsuranceAgreementsLiabilityExcludingAtFairValueUnderFairValueOption	22533000000	usd
CY2022Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	2635000000	usd
CY2022Q4	us-gaap	Securities Loaned SecuritiesLoaned	36000000	usd
CY2022Q4	us-gaap	Assets Sold Under Agreements To Repurchase Repurchase Liability AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability	1012000000	usd
CY2022Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	195906000000	usd
CY2023Q1	us-gaap	Deferred Policy Acquisition Costs Text Block1 DeferredPolicyAcquisitionCostsTextBlock1	Deferred Acquisition Costs<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This note contains the new accounting policy for the adoption of LDTI</span></div><div style="padding-right:-18.35pt;text-align:justify"><span><br/></span></div><div style="padding-left:0.18pt;padding-right:-18.35pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain costs that are directly related to the successful acquisition of new or renewal insurance business are capitalized as deferred acquisition costs in the period they are incurred. These costs primarily pertain to commissions and certain costs associated with policy issuance and underwriting. All other acquisition costs are expensed as incurred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Contracts are grouped into cohorts by contract type and issue year. For traditional and limited-payment insurance contracts, contracts are grouped consistent with the groupings used in estimating the associated liability. Deferred acquisition costs are amortized into expense on a constant level basis over the expected term of the grouped contracts. For traditional and limited-payment insurance contracts, amortization is determined based on projected in force amounts. For non-traditional contracts, amortization is determined based on projected policy counts</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:0.18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The expected term used to amortize deferred acquisition costs is determined using best estimate assumptions, including mortality and persistency, consistent with the best estimate assumptions used to determine the reserve for future policy benefits, market risk benefits, and additional liabilities for applicable contracts. For amortization of deferred acquisition costs related to contracts without these balances, assumptions used to determine expected term are developed in a similar manner. The amortization rate is determined using all information available as of the end of the reporting period, including actual experience and any assumption updates. Annually, or as circumstances warrant, a comprehensive review of assumptions is conducted and assumptions are revised as appropriate. If assumptions are revised, the amortization rate is calculated using revised assumptions such that the effect of revised assumptions is recognized prospectively as of the beginning of that reporting period. </span></div><div style="padding-left:0.18pt;text-align:justify"><span><br/></span></div><div style="padding-left:0.18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unamortized deferred acquisition costs are written off when a contract is internally replaced and substantially changed. Substantially unchanged contracts are treated as a continuation of the replaced contract, with no change to the unamortized deferred acquisition costs at the time of the replacement. </span></div><div style="padding-left:0.18pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the roll-forward of the deferred acquisition costs (in millions, 2022 information recast for the adoption of LDTI). The current period amortization is based on the end of the period estimates of mortality and persistency. The amortization pattern is revised on a prospective basis at the beginning of the period based on the period’s actual experience.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.917%"><tr><td style="width:1.0%"/><td style="width:67.129%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.636%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Variable Annuities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance, beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,699 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13,364 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Deferrals of acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">104 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">544 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(288)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,209)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Variable Annuities balance, end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,515 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,699 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Reconciliation of total deferred acquisition costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Variable Annuities balance, end of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,515 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,699 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other product lines, end of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">224 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total balance, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,760 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,923 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
CY2023Q1	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	245000000	usd
CY2022Q4	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	224000000	usd
CY2023Q1	us-gaap	Deferred Policy Acquisition Costs And Value Of Business Acquired DeferredPolicyAcquisitionCostsAndValueOfBusinessAcquired	12760000000	usd
CY2022Q4	us-gaap	Deferred Policy Acquisition Costs And Value Of Business Acquired DeferredPolicyAcquisitionCostsAndValueOfBusinessAcquired	12923000000	usd
CY2023Q1	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	15000000	usd
CY2022Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	15000000	usd
CY2023Q1	us-gaap	Reinsurance Receivables Case Basis ReinsuranceReceivablesCaseBasis	712000000	usd
CY2022Q4	us-gaap	Reinsurance Receivables Case Basis ReinsuranceReceivablesCaseBasis	787000000	usd
CY2023Q1	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	28078000000	usd
CY2022Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	29046000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Reinsurance Recoverable After Allowance MarketRiskBenefitReinsuranceRecoverableAfterAllowance	238000000	usd
CY2022Q4	us-gaap	Market Risk Benefit Reinsurance Recoverable After Allowance MarketRiskBenefitReinsuranceRecoverableAfterAllowance	221000000	usd
CY2023Q1	jxn	Funds Held Under Reinsurance Agreements Asset Liability Net FundsHeldUnderReinsuranceAgreementsAssetLiabilityNet	22508000000	usd
CY2022Q4	jxn	Funds Held Under Reinsurance Agreements Asset Liability Net FundsHeldUnderReinsuranceAgreementsAssetLiabilityNet	23226000000	usd
CY2023Q1	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	22254000000	usd
CY2022Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	22957000000	usd
CY2023Q1	jxn	Liability For Future Policy Benefit Before Reinsurance Reserve LiabilityForFuturePolicyBenefitBeforeReinsuranceReserve	9687000000	usd
CY2022Q4	jxn	Liability For Future Policy Benefit Before Reinsurance Reserve LiabilityForFuturePolicyBenefitBeforeReinsuranceReserve	9637000000	usd
CY2023Q1	jxn	Liability For Future Policy Benefit Before Reinsurance Additional Liabilities For Insurance Guarantees LiabilityForFuturePolicyBenefitBeforeReinsuranceAdditionalLiabilitiesForInsuranceGuarantees	1117000000	usd
CY2022Q4	jxn	Liability For Future Policy Benefit Before Reinsurance Additional Liabilities For Insurance Guarantees LiabilityForFuturePolicyBenefitBeforeReinsuranceAdditionalLiabilitiesForInsuranceGuarantees	1131000000	usd
CY2023Q1	jxn	Liability For Future Policy Benefit Before Reinsurance Other Insurance And Annuity Liabilities LiabilityForFuturePolicyBenefitBeforeReinsuranceOtherInsuranceAndAnnuityLiabilities	1565000000	usd
CY2022Q4	jxn	Liability For Future Policy Benefit Before Reinsurance Other Insurance And Annuity Liabilities LiabilityForFuturePolicyBenefitBeforeReinsuranceOtherInsuranceAndAnnuityLiabilities	1550000000	usd
CY2023Q1	jxn	Policyholder Account Balance Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense PolicyholderAccountBalanceLiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	12369000000	usd
CY2022Q4	jxn	Policyholder Account Balance Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense PolicyholderAccountBalanceLiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	12318000000	usd
CY2023Q1	us-gaap	Liability For Future Policy Benefit Gross Premium Income LiabilityForFuturePolicyBenefitGrossPremiumIncome	68000000	usd
CY2022	us-gaap	Liability For Future Policy Benefit Gross Premium Income LiabilityForFuturePolicyBenefitGrossPremiumIncome	400000000	usd
CY2023Q1	us-gaap	Liability For Future Policy Benefit Interest Expense LiabilityForFuturePolicyBenefitInterestExpense	102000000	usd
CY2022	us-gaap	Liability For Future Policy Benefit Interest Expense LiabilityForFuturePolicyBenefitInterestExpense	420000000	usd
CY2023Q1	jxn	Funding Agreement FundingAgreement	2200000000	usd
CY2022Q4	jxn	Funding Agreement FundingAgreement	2100000000	usd
CY2023Q1	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	57094000000	usd
CY2022Q4	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	58190000000	usd
CY2023Q1	us-gaap	Separate Account Assets SeparateAccountAssets	204000000000	usd
CY2022Q4	us-gaap	Separate Account Assets SeparateAccountAssets	196000000000	usd
CY2023Q1	us-gaap	Separate Account Assets SeparateAccountAssets	204366000000	usd
CY2022Q4	us-gaap	Separate Account Assets SeparateAccountAssets	195906000000	usd
CY2023Q1	us-gaap	Separate Account Assets SeparateAccountAssets	204366000000	usd
CY2022Q4	us-gaap	Separate Account Assets SeparateAccountAssets	195906000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	5204000000	usd
CY2022Q4	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	4865000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	5560000000	usd
CY2022Q4	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	5662000000	usd
CY2023Q1	us-gaap	Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk	356000000	usd
CY2022Q4	us-gaap	Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk	797000000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	2632000000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	2635000000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	598000000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	usd
CY2023Q1	jxn	Long Term Debt Maturity Year Five And Thereafter LongTermDebtMaturityYearFiveAndThereafter	2034000000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	2632000000	usd
CY2023Q1	us-gaap	Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch	0	usd
CY2022Q4	us-gaap	Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch	0	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.272
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.150
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.196
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4000000	usd
CY2023Q1	jxn	Asset Based Commission Expense AssetBasedCommissionExpense	250000000	usd
CY2022Q1	jxn	Asset Based Commission Expense AssetBasedCommissionExpense	275000000	usd
CY2023Q1	jxn	Other Commission Expense OtherCommissionExpense	174000000	usd
CY2023Q1	jxn	Number Of Classes Of Common Stock NumberOfClassesOfCommonStock	2	class
CY2022Q1	jxn	Other Commission Expense OtherCommissionExpense	240000000	usd
CY2023Q1	jxn	Sub Advisor Expenses SubAdvisorExpenses	77000000	usd
CY2022Q1	jxn	Sub Advisor Expenses SubAdvisorExpenses	90000000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	236000000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	241000000	usd
CY2023Q1	jxn	Deferral Of Acquisition Costs And Sales Inducement Assets DeferralOfAcquisitionCostsAndSalesInducementAssets	121000000	usd
CY2022Q1	jxn	Deferral Of Acquisition Costs And Sales Inducement Assets DeferralOfAcquisitionCostsAndSalesInducementAssets	180000000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	616000000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	666000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	1027000000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-3581000000	usd
CY2023Q1	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Before Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentBeforeTax	-146000000	usd
CY2022Q1	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Before Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentBeforeTax	765000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-284000000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-936000000	usd
CY2023Q1	jxn	Oci Other Unrealized Gain Loss Before Reclassifications Net Of Tax OCIOtherUnrealizedGainLossBeforeReclassificationsNetOfTax	-14000000	usd
CY2022Q1	jxn	Oci Other Unrealized Gain Loss Before Reclassifications Net Of Tax OCIOtherUnrealizedGainLossBeforeReclassificationsNetOfTax	9000000	usd
CY2023Q1	jxn	Oci Increase Decrease In Deferred Tax Asset Before Reclassifications Net Of Tax OCIIncreaseDecreaseInDeferredTaxAssetBeforeReclassificationsNetOfTax	-110000000	usd
CY2022Q1	jxn	Oci Increase Decrease In Deferred Tax Asset Before Reclassifications Net Of Tax OCIIncreaseDecreaseInDeferredTaxAssetBeforeReclassificationsNetOfTax	402000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	1041000000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-1469000000	usd
CY2023Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-29000000	usd
CY2022Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	10000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1070000000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1479000000	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	450000000	usd
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82690098	shares
CY2023Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	75957	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	-1721737	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81044318	shares
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.62
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.55
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1497000000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2194000000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	82646113	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86352586	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3607276	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82646113	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89959862	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-18.11
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	25.41
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-18.11
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	24.39
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3436857000000	shares
CY2022Q1	jxn	Reclassification Impacts In Cash Flows ReclassificationImpactsInCashFlows	27000000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001822993-23-000024-index-headers.html	Edgar Link	pending
0001822993-23-000024-index.html	Edgar Link	pending
0001822993-23-000024.txt	Edgar Link	pending
0001822993-23-000024-xbrl.zip	Edgar Link	pending
a1aruna.jpg	Edgar Link	pending
a1lauraa.jpg	Edgar Link	pending
a1marciaa.jpg	Edgar Link	pending
exhibit101dcummings2023rsu.htm	Edgar Link	pending
exhibit105-jacksonxmmlagre.htm	Edgar Link	pending
exhibit311_q1-2023.htm	Edgar Link	pending
exhibit312_q1-2023.htm	Edgar Link	pending
exhibit321_q1-2023.htm	Edgar Link	pending
exhibit322_q1-2023.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
image_1.jpg	Edgar Link	pending
image_3a.jpg	Edgar Link	pending
jxn-20230331.htm	Edgar Link	pending
jxn-20230331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
jxn-20230331_cal.xml	Edgar Link	unprocessable
jxn-20230331_def.xml	Edgar Link	unprocessable
jxn-20230331_pre.xml	Edgar Link	unprocessable
jxn-20230331_lab.xml	Edgar Link	unprocessable
jxn-20230331_htm.xml	Edgar Link	completed
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R131.htm	Edgar Link	pending
R132.htm	Edgar Link	pending
R133.htm	Edgar Link	pending
R134.htm	Edgar Link	pending
R135.htm	Edgar Link	pending
R136.htm	Edgar Link	pending
R137.htm	Edgar Link	pending
R138.htm	Edgar Link	pending
R139.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R140.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JXN
Jackson Financial Inc. Stock $jxn

2023 Q2 Form 10-Q Financial Statement

#000182299323000024 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JXN Jackson Financial Inc. Stock $jxn

2023 Q2 Form 10-Q Financial Statement

#000182299323000024 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JXN
Jackson Financial Inc. Stock $jxn